← Browse by Condition
Medical Condition

for contrast enhanced magnetic resonance imaging mri of central nervous system cns lesions

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3

ClinicalMetric tracks all active clinical trials for for contrast enhanced magnetic resonance imaging mri of central nervous system cns lesions sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 3
1
Top Sponsors
Shanghai Shengdi Pharmaceutical Co., Ltd 1 trial
NCT07275814 Phase 3
Recruiting

A Study of a Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Central Nervous System (CNS) Lesions

Enrollment
250 pts
Location
China
Sponsor
Shanghai Shengdi Pharmaceutica...
View Trial →